Survival of Patients With True Pathologic Stage I Non-Small Cell Lung Cancer
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery
Reference17 articles.
1. Non-small cell lung cancer: part I;Ihde;Curr Probl Cancer,1991
2. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage 1 Non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study;Onishi;J Thor Oncol,2007
3. Computed tomography-guided frameless stereotactic radiotherapy for stage 1 and non-small-cell lung cancer: a 5-year experience;Uematsu;Int J Radiat Oncol Biol Phys,2001
4. Promising clinical outcomes of stereotactic body radiation therapy for patients with inoperable stage I/II non-small cell lung cancer;Xia;Int J Radiat Oncol Biol Phys,2006
5. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame;Nagata;Int J Radiat Oncol Biol Phys,2005
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Early detection of lung cancer using artificial intelligence-enhanced optical nanosensing of chromatin alterations in field carcinogenesis;Scientific Reports;2023-08-22
2. Surgical Effectiveness of Uniportal-VATS Lobectomy Compared to Open Surgery in Early-Stage Lung Cancer;Frontiers in Surgery;2022-03-04
3. Comparison of first-generation EGFR-TKIs (gefitinib, erlotinib, and icotinib) as adjuvant therapy in resected NSCLC patients with sensitive EGFR mutations;Translational Lung Cancer Research;2021-12
4. A Propensity-Matched Analysis of Survival of Clinically Diagnosed Early-Stage Lung Cancer and Biopsy-Proven Early-Stage Non-Small Cell Lung Cancer Following Stereotactic Ablative Radiotherapy;Frontiers in Oncology;2021-08-24
5. Oncologic Outcomes of Surgery Versus SBRT for Non–Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis;Clinical Lung Cancer;2021-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3